Alaunos Therapeutics, Inc.
Ticker: 1107421
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY25 | Q2 FY24 | Q2 FY24 | Q1 FY24 | Q2 FY23 | Q3 FY22 | Q3 FY22 | Q3 FY21 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 2.91+0.0% | 2.91+627.5% | 0.40 |
| Total Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 2.91+0.0% | 2.91+627.5% | 0.40 |
| EXPENSES | ||||||||
| Expenditure | 1.09-6.8% | 1.17+0.0% | 1.17-32.8% | 1.74-78.2% | 7.99-28.5% | 11.18+0.0% | 11.18-50.7% | 22.69 |
| PROFIT | ||||||||
| Net Profit | -1.07+5.3% | -1.13+0.0% | -1.13+32.7% | -1.68+80.8% | -8.77+0.9% | -8.85+0.0% | -8.85+61.1% | -22.73 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.67+5.6% | -0.71+0.0% | -0.71-545.5% | -0.11-175.0% | -0.04+0.0% | -0.04+0.0% | -0.04 | — |
Corporate Events
No corporate events found.